These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24594996)

  • 1. CD74: a new prognostic factor for patients with malignant pleural mesothelioma.
    Otterstrom C; Soltermann A; Opitz I; Felley-Bosco E; Weder W; Stahel RA; Triponez F; Robert JH; Serre-Beinier V
    Br J Cancer; 2014 Apr; 110(8):2040-6. PubMed ID: 24594996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MIF/CD74 signaling pathway in the development of pleural mesothelioma.
    D'Amato-Brito C; Cipriano D; Colin DJ; Germain S; Seimbille Y; Robert JH; Triponez F; Serre-Beinier V
    Oncotarget; 2016 Mar; 7(10):11512-25. PubMed ID: 26883190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.
    Ekmekcioglu S; Davies MA; Tanese K; Roszik J; Shin-Sim M; Bassett RL; Milton DR; Woodman SE; Prieto VG; Gershenwald JE; Morton DL; Hoon DS; Grimm EA
    Clin Cancer Res; 2016 Jun; 22(12):3016-24. PubMed ID: 26783288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.
    Schramm A; Opitz I; Thies S; Seifert B; Moch H; Weder W; Soltermann A
    Eur J Cardiothorac Surg; 2010 Mar; 37(3):566-72. PubMed ID: 19781955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.
    Verjans E; Noetzel E; Bektas N; Schütz AK; Lue H; Lennartz B; Hartmann A; Dahl E; Bernhagen J
    BMC Cancer; 2009 Jul; 9():230. PubMed ID: 19602265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
    Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
    World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma.
    Valdez CN; Sánchez-Zuno GA; Osmani L; Ibrahim W; Galan A; Bacchiocchi A; Halaban R; Kulkarni RP; Kang I; Bucala R; Tran T
    Oncotarget; 2024 Jul; 15():507-520. PubMed ID: 39028303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide.
    Lapter S; Ben-David H; Sharabi A; Zinger H; Telerman A; Gordin M; Leng L; Bucala R; Shachar I; Mozes E
    Immunology; 2011 Jan; 132(1):87-95. PubMed ID: 20738420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer.
    McClelland M; Zhao L; Carskadon S; Arenberg D
    Am J Pathol; 2009 Feb; 174(2):638-46. PubMed ID: 19131591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma.
    Thapa B; Walkiewicz M; Murone C; Asadi K; Deb S; Barnett S; Knight S; Mitchell P; Liew D; Watkins DN; John T
    Pathology; 2016 Dec; 48(7):660-665. PubMed ID: 27780599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
    Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S
    Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival of mesenchymal stem cells by macrophage migration inhibitory factor.
    Xia W; Xie C; Jiang M; Hou M
    Mol Cell Biochem; 2015 Jun; 404(1-2):11-24. PubMed ID: 25701358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair.
    Marsh LM; Cakarova L; Kwapiszewska G; von Wulffen W; Herold S; Seeger W; Lohmeyer J
    Am J Physiol Lung Cell Mol Physiol; 2009 Mar; 296(3):L442-52. PubMed ID: 19136583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
    Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
    Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.
    Pasello G; Urso L; Mencoboni M; Grosso F; Ceresoli GL; Lunardi F; Vuljan SE; Bertorelle R; Sacchetto V; Ciminale V; Rea F; Favaretto A; Conte P; Calabrese F
    Oncotarget; 2015 Dec; 6(39):42053-66. PubMed ID: 26544728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD74 expression and its therapeutic potential in thyroid carcinoma.
    Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ
    Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.
    Cheng RJ; Deng WG; Niu CB; Li YY; Fu Y
    Int J Gynecol Cancer; 2011 Aug; 21(6):1004-12. PubMed ID: 21792010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.
    Cedrés S; Montero MA; Zamora E; Martínez A; Martínez P; Fariñas L; Navarro A; Torrejon D; Gabaldon A; Ramon Y Cajal S; Felip E
    Clin Transl Oncol; 2014 Sep; 16(9):776-82. PubMed ID: 24323466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.
    Heinrichs D; Knauel M; Offermanns C; Berres ML; Nellen A; Leng L; Schmitz P; Bucala R; Trautwein C; Weber C; Bernhagen J; Wasmuth HE
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17444-9. PubMed ID: 21969590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.